TrialLipids in health and disease2018

Metabolomics identifies increases in the acylcarnitine profiles in the plasma of overweight subjects in response to mild weight loss: a randomized, controlled design study.

Miso Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.